Los puntos clave no están disponibles para este artículo en este momento.
NASH is currently the second leading cause for LT waitlist registration/liver transplantation overall, and in females, the leading cause. Given the rate of increase, NASH will likely rise to become the leading indication for LT in males as well.
Noureddin et al. (Wed,) studied this question.